Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy A Gattis

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The American Journal of Cardiology|May 18, 2004
Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failureWendy A Gattis, Christopher M O'Connor
Reviews in Cardiovascular Medicine|November 26, 2002
Treatment gaps in the pharmacologic management of heart failureMihai Gheorghiade, Wendy A Gattis, Christopher M O'Connor
Reviews in Cardiovascular Medicine|November 26, 2002
The Initiation Management Predischarge Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) Study: design and implicationsWendy A Gattis, Christopher M O'Connor, Mihai Gheorghiade
Journal of the American College of Cardiology|September 1, 2004
Anemia as a risk factor and therapeutic target in heart failureG Michael Felker, Kirkwood F Adams, Wendy A Gattis, et al.
Journal of the American College of Cardiology|May 4, 2004
Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trialWendy A Gattis, Christopher M O'Connor, Dianne S Gallup, et al.
The American Journal of Cardiology|April 20, 2004
Effects of amino acid supplementation on left ventricular remodeling in patients with chronic heart failure with decreased systolic function and diabetes mellitus: rationale and design of a magnetic resonance imaging studyLiviu Klein, Wendy A Gattis, Francesco Borrello, et al.
The American Journal of Cardiology|May 29, 2004
Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial)Wendy A Gattis, Christopher M O'Connor, Vic Hasselblad, et al.
American Heart Journal|June 25, 2004
Racial differences in the outcomes of patients with diastolic heart failureMark A East, Eric D Peterson, Linda K Shaw, et al.
The American Journal of Cardiology|January 11, 2003
Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failureWendy A Gattis, Christopher M O'Connor, Jeffrey D Leimberger, et al.
American Heart Journal|October 3, 2002
Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the Randomized Intravenous Tezosentan study (RITZ-4)Christopher M O'Connor, Wendy A Gattis, Kirkwood F Adams, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The American Journal of Cardiology|May 18, 2004
Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failureWendy A Gattis, Christopher M O'Connor
Reviews in Cardiovascular Medicine|November 26, 2002
Treatment gaps in the pharmacologic management of heart failureMihai Gheorghiade, Wendy A Gattis, Christopher M O'Connor
Reviews in Cardiovascular Medicine|November 26, 2002
The Initiation Management Predischarge Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) Study: design and implicationsWendy A Gattis, Christopher M O'Connor, Mihai Gheorghiade
Journal of the American College of Cardiology|September 1, 2004
Anemia as a risk factor and therapeutic target in heart failureG Michael Felker, Kirkwood F Adams, Wendy A Gattis, et al.
Journal of the American College of Cardiology|May 4, 2004
Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trialWendy A Gattis, Christopher M O'Connor, Dianne S Gallup, et al.
The American Journal of Cardiology|April 20, 2004
Effects of amino acid supplementation on left ventricular remodeling in patients with chronic heart failure with decreased systolic function and diabetes mellitus: rationale and design of a magnetic resonance imaging studyLiviu Klein, Wendy A Gattis, Francesco Borrello, et al.
The American Journal of Cardiology|May 29, 2004
Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial)Wendy A Gattis, Christopher M O'Connor, Vic Hasselblad, et al.
American Heart Journal|June 25, 2004
Racial differences in the outcomes of patients with diastolic heart failureMark A East, Eric D Peterson, Linda K Shaw, et al.
The American Journal of Cardiology|January 11, 2003
Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failureWendy A Gattis, Christopher M O'Connor, Jeffrey D Leimberger, et al.
American Heart Journal|October 3, 2002
Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the Randomized Intravenous Tezosentan study (RITZ-4)Christopher M O'Connor, Wendy A Gattis, Kirkwood F Adams, et al.
Pageof 2